RMH clonoSEQ® Assay
Key facts
- Contract value
- £1,158,208
- Awarded
- 22 Dec 2025
- Contract starts
- 20 Jan 2026
- Contract ends
- 19 Jan 2031
- Procedure
- Direct award
- Buyer type
- Health
- Source
- Find a Tender
Awarded to
| Supplier | Value |
|---|---|
| Adaptive Biotechnologies Corporation | £1,158,208 |
Description
The procurement of a next-generation sequencing (NGS)–based test assay designed for the detection and monitoring of minimal residual disease (MRD) in patients with certain haematologic malignancies, such as multiple myeloma, acute lymphoblastic leukaemia (ALL), and chronic lymphocytic leukaemia (CLL). The required goods and services include: • Provision of assay kits and reagents suitable for the intended patient population. • Use of a software platform for analysis and reporting of results. • Training and technical support for laboratory and clinical staff to ensure accurate sample processing, data interpretation, and integration into clinical workflows. • Ongoing technical support, maintenance, and updates for both hardware (if applicable) and software components. • Delivery of consumables and reagents on a schedule that aligns with clinical demand, ensuring continuity of patient testing. • Compliance with all relevant regulatory standards (e.g., CE-IVD, UKCA marking) and data protection requirements for patient information. • Optional: Integration with existing laboratory information management systems (LIMS) and electronic health records (EHR), if required. • MRD sensitivity threshold of 10-5 or lower • Must work on DNA • Performance data must be supported by evidence generated in relevant disease specific Clinical Trials • Recognised technology included in clinical guidelines • Ability to track clonal evolution
Categories (CPV)
- 33696500 Laboratory reagents
Similar open tenders
Global Travel, Accommodation and Venue Management Services
Location: North WestBuyer: Government Commercial Agency
Open tenderCloses 8 Dec, 202633 daysValue £36.25bnSource Find a TenderA framework providing comprehensive booking solutions for all UK Public Sector Travel needs, including air, rail, taxis, coaches, car hire, accommodation and venues for meetings, conferences and events, as well as emergency travel and accommodation solutions, including for civilian cohorts under the care of a UK Public
National Generic Pharmaceuticals – Project Revive
Location: LondonBuyer: NHS England
Open tenderCloses 30 Nov, 202625 daysValue £6.86mSource Find a TenderNational Generic Pharmaceuticals – Project Revive DCE/DSW regions – 01/04/27 to 31/01/29 (22 months) DLS/DNE regions – 01/04/27 to 31/01/29 (22 months) DLN/DNW regions – 01/04/27 to 31/01/29 (22 months)
Orthotic Splints & Braces
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 13 Nov, 20268 daysValue £60.14kSource Find a TenderOrthotic Splints & Braces - RJAH, SATH , SCT
UKRI-6412 MRC Harwell Self-Steam Generating Autoclave
Location: South WestBuyer: UK Research & Innovation (UKRI)
Open tenderCloses 30 Nov, 202625 daysValue £150.00kSource Find a TenderMRC Harwell is seeking to replace the existing autoclave with the supply, installation and acceptance of a self-steaming generating autoclave
Cleanroom Consumables
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 9 Nov, 20264 daysValue £11.91kSource Find a TenderCleanroom Consumables - SATH & SCT
MED0014 - The Supply of Beating Heart Products
Location: United KingdomBuyer: University Hospitals of North Midlands NHS Trust
Open tenderCloses 16 Nov, 202611 daysValue £18.33kSource Find a TenderBeating heart surgery (Off-Pump Coronary Artery Bypass or OPCAB) utilizes specific stabilization equipment rather than a cardiopulmonary bypass machine.